Poor responses to tyrosine kinase inhibitors in a child with precursor B-cell acute lymphoblastic leukemia withSNX2-ABL1chimeric transcript

Author:

Masuzawa Aki1,Kiyotani Chikako1,Osumi Tomoo1,Shioda Yoko1,Iijima Kazutoshi23,Tomita Osamu2,Nakabayashi Kazuhiko4,Oboki Keisuke5,Yasuda Kazuki6,Sakamoto Hiromi7,Ichikawa Hitoshi7,Hata Kenichiro4,Yoshida Teruhiko7,Matsumoto Kenji5,Kiyokawa Nobutaka2,Mori Tetsuya1

Affiliation:

1. Division of Pediatric Oncology; National Center for Child Health and Development; Setagaya-ku Japan

2. Department of Pediatric Hematology and Oncology Research; National Research Institute for Child Health and Development; Setagaya-ku Japan

3. Department of Industrial Chemistry; Faculty of Engineering; Tokyo University of Science; Shinjuku-ku Japan

4. Department of Maternal-Fetal Biology; National Research Institute for Child Health and Development; Setagaya-ku Japan

5. Department of Allergy and Immunology; National Research Institute for Child Health and Development; Setagaya-ku Japan

6. Department of Metabolic Disorder; Diabetes Research Center; National Center for Global Health and Medicine; Shinjuku-ku Japan

7. Division of Genetics; National Cancer Center Research Institute; Chuo-ku Tokyo Japan

Publisher

Wiley

Subject

Hematology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3